Arrowstreet Capital’s BioAge Labs BIOA Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOA
Arrowstreet Capital's BIOA Position: Q3 2026 in Review
Arrowstreet Capital sold out of BioAge Labs (BIOA) in Q3 2026, closing a stake of 49,545 shares — an estimated $1.21M sold.
Arrowstreet Capital first reported a position in BIOA in Q1 2026 and held it in 2 quarters. The position peaked at $1.54M in Q1 2026. 162 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.
- Arrowstreet Capital reported no remaining BioAge Labs position as of Q3 2026 after selling out during the quarter.
- Arrowstreet Capital sold 49,545 BioAge Labs shares in Q3 2026, an estimated $1.21M.
- Arrowstreet Capital first reported a position in BioAge Labs in Q1 2026 and held it in 2 quarters.
- Arrowstreet Capital's BioAge Labs position peaked at $1.54M in Q1 2026.
- 162 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.
Based on Arrowstreet Capital's 13F filing for Q3 2026, filed 13 Nov 2026.